Ingevity (NYSE:NGVT) Shares Gap Down – Should You Sell?

Ingevity Corporation (NYSE:NGVT) gapped down prior to trading on Thursday . The stock had previously closed at $73.99, but opened at $69.88. Ingevity shares last traded at $69.4310, with a volume of 10,741 shares changing hands.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on NGVT shares. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 1st. Weiss Ratings raised Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a report on Friday, July 31st. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $80.00.

Ingevity Trading Up 1.1%

The business’s 50-day moving average price is $73.84 and its two-hundred day moving average price is $71.83. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15. The firm has a market cap of $2.41 billion, a price-to-earnings ratio of 47.67 and a beta of 1.16.

Ingevity (NYSE:NGVT) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The business had revenue of $314.10 million for the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Equities analysts expect that Ingevity Corporation will post 5.4 earnings per share for the current year.

Insiders Place Their Bets

In related news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the transaction, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO David H. Li sold 5,000 shares of the company’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the transaction, the chief executive officer owned 120,636 shares of the company’s stock, valued at $9,147,827.88. The trade was a 3.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 18,297 shares of company stock valued at $1,381,452 in the last quarter. 0.88% of the stock is currently owned by company insiders.

Institutional Trading of Ingevity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Global Retirement Partners LLC acquired a new position in shares of Ingevity during the 4th quarter valued at about $27,000. Meeder Asset Management Inc. acquired a new stake in shares of Ingevity in the fourth quarter worth approximately $33,000. Geneos Wealth Management Inc. boosted its position in shares of Ingevity by 85.8% in the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after acquiring an additional 387 shares during the last quarter. Frazier Financial Advisors LLC purchased a new stake in Ingevity in the second quarter valued at approximately $37,000. Finally, Headlands Technologies LLC purchased a new stake in Ingevity in the second quarter valued at approximately $46,000. Hedge funds and other institutional investors own 91.59% of the company’s stock.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.